Report #2871131

Overview

Sex

Female

Age

Age unknown

State

KS

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

An adult patient received two pediatric doses of Engerix-B at the same time.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult use of a child product in a 31-year-old female patient who received HBV (Engerix B pediatric) (batch number D3X3E, expiry date 20-AUG-2027) for prophylaxis. Co-suspect products included HBV (Engerix B pediatric) for prophylaxis. On an unknown date, the patient received Engerix B pediatric and Engerix B pediatric. On an unknown date, an unknown time after receiving Engerix B pediatric and Engerix B pediatric, the patient experienced adult use of a child product (Verbatim: An adult patient received two pediatric doses of Engerix-B at the same time.). The outcome of the adult use of a child product was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-OCT-2025 The pharmacist reported that the administration of two pediatric doses of Engerix B to an adult female patient at the same time. The reporter was ask was there a contraindication for this, was there any information to support this. The reporter was ask did the patient needs the adult dose or how do we have to procced.